In addition to its role as a practice guideline appraisal tool, the AGREE II can be used as a framework to guide practice guideline development. The AGREE II can serve as a methodological strategy for guideline development and can inform what information and how this information ought to be reported (AGREE II, Introduction). By applying AGREE II as a development framework, guideline developers are aware of the criteria on which they will be assessed.
The Capacity Enhancement Program (CEP) of the Canadian Partnership Against Cancer (CPAC) developed a valuable resource for how the AGREE II can be used for practice guideline development. The resource is organized by AGREE II domains and includes examples of well-developed content for each AGREE II item. The resource is located on the Canadian CancerView website and you may link directly to each section below: